|
Name |
(+)-Eremophilene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
(3S,4aS,5R)-4a,5-dimethyl-3-prop-1-en-2-yl-2,3,4,5,6,7-hexahydro-1H-naphthalene
|
|
SMILES |
C[C@@H]1CCC=C2[C@]1(C[C@H](CC2)C(=C)C)C
|
|
InChI |
InChI=1S/C15H24/c1-11(2)13-8-9-14-7-5-6-12(3)15(14,4)10-13/h7,12-13H,1,5-6,8-10H2,2-4H3/t12-,13+,15+/m1/s1
|
|
InChIKey |
QEBNYNLSCGVZOH-IPYPFGDCSA-N
|
|
Synonyms |
(+)-eremophilene; (3S,4aS,5R)-4a,5-dimethyl-3-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene; Naphthalene, 1,2,3,5,6,7,8,8a-octahydro-1,8a-dimethyl-7-(1-methylethenyl)-, [1S-(1.alpha.,7.alpha.,8a.alpha.)]-; 3-Isopropenyl-4a,5-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalene #; CHEBI:137562; ZINC100779031; (3S,4aS,5R)-4a,5-dimethyl-3-prop-1-en-2-yl-2,3,4,5,6,7-hexahydro-1H-naphthalene; C21684
|
|
CAS | NA | |
PubChem CID | 6431897 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 5.2 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.518 |
Caco-2 Permeability: | -4.481 | MDCK Permeability: | 0.00001830 |
Pgp-inhibitor: | 0.015 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.923 |
30% Bioavailability (F30%): | 0.139 |
Blood-Brain-Barrier Penetration (BBB): | 0.227 | Plasma Protein Binding (PPB): | 89.23% |
Volume Distribution (VD): | 2.711 | Fu: | 9.09% |
CYP1A2-inhibitor: | 0.633 | CYP1A2-substrate: | 0.695 |
CYP2C19-inhibitor: | 0.364 | CYP2C19-substrate: | 0.933 |
CYP2C9-inhibitor: | 0.253 | CYP2C9-substrate: | 0.647 |
CYP2D6-inhibitor: | 0.131 | CYP2D6-substrate: | 0.683 |
CYP3A4-inhibitor: | 0.769 | CYP3A4-substrate: | 0.383 |
Clearance (CL): | 13.584 | Half-life (T1/2): | 0.087 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.33 |
Drug-inuced Liver Injury (DILI): | 0.131 | AMES Toxicity: | 0.016 |
Rat Oral Acute Toxicity: | 0.037 | Maximum Recommended Daily Dose: | 0.92 |
Skin Sensitization: | 0.543 | Carcinogencity: | 0.864 |
Eye Corrosion: | 0.893 | Eye Irritation: | 0.95 |
Respiratory Toxicity: | 0.907 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001924 | 1.000 | D07BSQ | 0.265 | ||||
ENC001829 | 0.673 | D04SFH | 0.253 | ||||
ENC001437 | 0.673 | D0B4RU | 0.250 | ||||
ENC001834 | 0.439 | D0Z1XD | 0.244 | ||||
ENC005064 | 0.435 | D0I2SD | 0.239 | ||||
ENC005063 | 0.435 | D0G8BV | 0.235 | ||||
ENC000786 | 0.414 | D0F1UL | 0.235 | ||||
ENC002392 | 0.414 | D06XMU | 0.235 | ||||
ENC000332 | 0.414 | D0K0EK | 0.235 | ||||
ENC002073 | 0.414 | D02CJX | 0.234 |